Story · Medicine & Biotech

Moderna's RSV vaccine shown to provide strong protection against serious cases in adults 50 and older

1 outlet · first reported by Medical Xpress 10h ago

Coverage, in order

  1. 10h ago
    Medical Xpress indie
    Moderna's RSV vaccine shown to provide strong protection against serious cases in adults 50 and older

    A single dose of Moderna's mResvia RSV vaccine was 60.3% protective against documented respiratory syncytial virus (RSV) infections, 60.2% against RSV-associated emergency department or urgent care encounters and 81.8% against RSV-associated hospitalizations in a population of older U.S. veterans…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.